Skip to main content
main-content
Top

06-03-2017 | Melanoma | Article

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

Dummer R et al. Lancet Oncol 2017; 18(4): 435-445. doi:10.1016/S1470-2045(17)30180-8

Please log in to get access to this content

Related topics